Xeljanz (ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults

You'll see Xeljanz ( ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults.

Think of Xeljanz as an alternative to Humira (adalimumab).

Expect to see Xeljanz used in combination with methotrexate...or used alone when methotrexate can't be taken due to side effects.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote